Guided Therapeutics, Inc. Stock
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
15:58:43 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.2900 USD | 0.00% |
|
0.00% | -46.30% |
| 07-14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 28M 24.28M 22.79M 20.76M 38.98M 2.67B 39.64M 268M 105M 1.34B 105M 103M 4.46B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 30.87M 26.77M 25.13M 22.89M 42.98M 2.95B 43.71M 295M 115M 1.48B 116M 113M 4.92B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | -3.33% | ||
| 1 month | -3.33% | ||
| 3 months | +45.00% | ||
| 6 months | -6.45% | ||
| Current year | -46.30% |
| 1 week | 0.24 | 0.29 | |
| 1 month | 0.24 | 0.3 | |
| Current year | 0.17 | 0.54 | |
| 1 year | 0.15 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 3,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/25/26 | Others | Director | 260 | 25.3411% | ||
| 2/25/26 | Option | Chairman | 600,000 | 0.7177% | ||
| 2/25/26 | Fiscal year | Director | 8,477,131 | 10.1402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +48.72% | +70.59% | 28M | ||
| -1.18% | +3.13% | +24.82% | +9.58% | 223B | ||
| -0.92% | +2.12% | -0.89% | -20.17% | 145B | ||
| 0.00% | +6.95% | -16.09% | +31.78% | 142B | ||
| +0.53% | +8.27% | -49.64% | +1.29% | 74.52B | ||
| -0.53% | +4.04% | +20.32% | +16.56% | 53.63B | ||
| +0.03% | -0.51% | -15.63% | -17.27% | 50.14B | ||
| +0.71% | +5.80% | +27.25% | +17.68% | 41.87B | ||
| -0.63% | +3.38% | +44.83% | +41.78% | 40.89B | ||
| +2.09% | +5.05% | -0.83% | +3.07% | 32.65B | ||
| Average | +0.09% | +3.81% | +8.29% | +15.49% | 80.31B | |
| Weighted average by Cap. | -0.34% | +4.56% | +3.34% | +7.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.07K 5.7K 5.19K 9.75K 668K 9.91K 66.93K 26.15K 335K 26.28K 25.71K 1.12M | 767K 665K 624K 569K 1.07M 73.19M 1.09M 7.33M 2.86M 36.69M 2.88M 2.82M 122M |
| Net income | -2.42M -2.1M -1.97M -1.79M -3.36M -231M -3.42M -23.11M -9.03M -116M -9.07M -8.88M -385M | -3.2M -2.77M -2.6M -2.37M -4.45M -305M -4.53M -30.56M -11.94M -153M -12M -11.74M -510M |
| Net Debt | 1.77M 1.54M 1.44M 1.31M 2.47M 169M 2.51M 16.93M 6.62M 84.71M 6.65M 6.5M 282M | 2.88M 2.49M 2.34M 2.13M 4M 274M 4.07M 27.5M 10.74M 138M 10.8M 10.56M 459M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | US$0.2900 | 0.00% | 3,162 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















